Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | BMY | AMGN | GSK | GILD |
| Company | Spero Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.4200 | 49.00 | 270.63 | 41.20 | 66.58 |
| High | 1.4500 | 49.04 | 274.86 | 41.24 | 67.18 |
| Low | 1.4100 | 48.55 | 269.64 | 40.63 | 66.36 |
| Last | 1.4200 | 48.86 | 273.01 | 40.86 | 67.08 |
| Change | -0.0150 | -0.13 | -0.53 | -0.38 | +0.05 |
| % Change | -1.05% | -0.27% | -0.19% | -0.92% | +0.07% |
| Volume | 110,000 | 16,057,100 | 2,467,100 | 1,816,100 | 8,467,000 |
| 20-Day Average Volume | 236,665 | 11,259,110 | 2,172,705 | 2,928,100 | 6,490,535 |
| Previous Close | 1.4350 | 48.99 | 273.54 | 41.24 | 67.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6120 | 50.37 | 271.55 | 40.97 | 69.07 |
| 20-Day Raw Stochastic | 11.36% | 18.15% | 44.22% | 41.94% | 14.81% |
| 20-Day Relative Strength | 38.28% | 41.15% | 48.18% | 47.80% | 33.12% |
| Weighted Alpha | -15.38 | -26.02 | +11.15 | +15.29 | -20.78 |
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 40% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 56% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.33% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +3.18% since 04/17/24 | +0.22% since 04/17/24 |
| Low | 1.3700 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 1.5500 on 04/18/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 41.26 on 04/23/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -18.86% since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -3.52% since 03/22/24 | -7.62% since 03/22/24 |
| Low | 1.3700 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 1.8100 on 04/02/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 43.45 on 03/25/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -9.55% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | +4.69% since 01/24/24 | -15.65% since 01/24/24 |
| Low | 1.3300 on 02/08/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 38.56 on 01/25/24 | 65.90 on 04/18/24 |
| High | 1.8900 on 03/14/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +33.96% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | +13.56% since 10/24/23 | -14.17% since 10/24/23 |
| Low | 0.9900 on 10/26/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 33.67 on 11/02/23 | 65.90 on 04/18/24 |
| High | 1.8900 on 03/14/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,336 | 99,290,928 | 146,720,288 | 85,467,432 | 83,457,512 |
| Shares Outstanding, K | 53,893 | 2,026,759 | 536,376 | 2,072,440 | 1,245,077 |
| Annual Sales | 103,780,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | 22,810,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 73,520,000 | 11,477,000,000 | 8,196,000,000 | 9,980,060,000 | 7,114,000,000 |
| Last Quarter Net Income | 51,190,000 | 1,762,000,000 | 767,000,000 | 433,200,000 | 1,429,000,000 |
| 60-Month Beta | 0.55 | 0.39 | 0.58 | 0.64 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.96 on 03/13/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.72 on 01/31/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 09/16/15 | 04/04/24 | 05/16/24 | 02/22/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 2.81 | 6.55 | 14.58 | 10.54 | 9.96 |